1346245-13-3

Upstream product

• 82031-32-1 7-bromo-1H-quinoxalin-2-one 
• 1346245-12-2 C₁₆H₁₅N₃O₃ 
• 10272-07-8 3.5-dimethoxyaniline 

Downstream Products

• 1346245-20-2 C₂₀H₂₀ClN₃O₂ 
• 1346245-14-4 C₂₅H₃₄ClN₃O₃Si 
• 1346245-07-5 C₂₂H₂₃N₅O₂ 
• 1346253-30-2 C₂₈H₃₇N₅O₃Si 
• 1346245-53-1 C₃₁H₄₂N₆O₄Si 
• 1346253-32-4 C₂₂H₂₃N₅O₃ 
• 1346253-33-5 C₂₃H₂₅N₅O₅S 
• 1431703-15-9 C₃₆H₃₉N₅O₈S 
• 1431703-14-8 C₄₂H₅₃N₅O₈SSi 
• 1431703-13-7 C₃₅H₄₇N₅O₆Si 
• 1431703-11-5 C₄₂H₃₇N₅O₂ 
• 1431703-10-4 C₂₁H₂₀N₄O₂ 
• 1431703-05-7 C₂₀H₂₂N₄O₂ 
• 1431703-04-6 C₂₂H₂₁N₃O₂ 

Relevant academic research and scientific papers

7-((3,5-DIMETHOXYPHENYL)AMINO)QUINOXALINE DERIVATIVES AS FGFR INHIBITORS FOR TREATING CANCER

Provided herein are 7-((3,5-dimethoxyphenyl)amino)quinoxaline derivatives of the general Formula I: and stereoisomers and pharmaceutically acceptable salts or solvates thereof, in which X 2 is N and Ring A, Ring B, Ring C, X 1, X su

ANTICANCER BENZOPYRAZINES VIA THE INHIBITION OF FGFR KINASES

The invention relates to new quinoxaline derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.

PYRAZOLYL QUINAZOLINE KINASE INHIBITORS

The invention relates to new quinoxaline derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.